Zheng Quan Zhi Xing·2025-06-24 19:03Core Viewpoint - The document outlines the information disclosure system of Shanghai Fosun Pharmaceutical (Group) Co., Ltd., emphasizing the importance of timely, accurate, and complete disclosure of information that may significantly impact the trading prices of the company's securities and derivatives. Group 1: General Principles - The information disclosure system is established to regulate the disclosure behavior of the company and related parties, ensuring the protection of the company's and investors' legal rights [1][2] - Information disclosure obligations apply to various parties, including the company's board of directors, senior management, shareholders, and other relevant individuals [2][3] - The board of directors is responsible for implementing the information disclosure system, with the chairman as the primary responsible person [3][4] Group 2: Basic Principles of Information Disclosure - Information must be disclosed in a timely and fair manner, ensuring that all investors receive the same information simultaneously [3][4] - Disclosure must be truthful, accurate, complete, and clear, without any misleading statements or significant omissions [3][4] - The company must adhere to legal and regulatory requirements for information disclosure, including those set by the Shanghai Stock Exchange and the Hong Kong Stock Exchange [4][5] Group 3: Content of Information Disclosure - The company is required to prepare and disclose periodic reports, including annual and interim reports, in accordance with relevant regulations [6][7] - Annual reports must include key information such as the company's basic situation, major accounting data, stock and bond issuance, and significant events during the reporting period [7][8] - The company must disclose any risks that may significantly impact its core competitiveness and future development [7][8] Group 4: Temporary Reports - Temporary reports must be disclosed for significant events that may impact the trading prices of the company's securities, including shareholder and board resolutions [9][10] - The company must immediately disclose any major events that investors are not yet aware of, detailing the cause, current status, and potential impact [9][10] Group 5: Internal Management of Information Disclosure - The board secretary's office is responsible for managing information disclosure, coordinating the collection and reporting of information to the board [13][14] - All departments and subsidiaries must report significant events to the board secretary promptly [18][19] - The company must establish internal procedures for the preparation, review, and disclosure of periodic reports [19][20] Group 6: Confidentiality and Accountability - Information disclosure obligations include maintaining confidentiality of undisclosed information and ensuring that insiders do not leak such information [21][22] - Individuals who fail to comply with disclosure requirements or cause significant omissions may face internal penalties and legal liabilities [22][23]